Shares of hVIVO plc (LON:HVO – Get Free Report) were up 10% on Monday . The stock traded as high as GBX 22 ($0.27) and last traded at GBX 21.25 ($0.26). Approximately 7,804,669 shares were traded during trading, an increase of 164% from the average daily volume of 2,961,263 shares. The stock had previously closed at GBX 19.33 ($0.24).
hVIVO Stock Down 6.9 %
The stock has a fifty day moving average price of GBX 20.01 and a two-hundred day moving average price of GBX 25.58. The company has a market cap of £129.27 million, a price-to-earnings ratio of 633.33 and a beta of 0.97. The company has a quick ratio of 1.16, a current ratio of 1.61 and a debt-to-equity ratio of 33.86.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Read More
- Five stocks we like better than hVIVO
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- 3 Steel Stocks Soaring After Tariff Announcements
- What Is WallStreetBets and What Stocks Are They Targeting?
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
